Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in postmenopausal women

Menopause

Volumn 15, Issue 2, 2008, Pages 326-331

  Ceresini, Graziano ^a,f   Milli, Bruna ^a   Morganti, Simonetta ^a   Maggio, Marcello ^a   Bacchi Modena, Alberto ^a   Sgarabotto, Maria Paola ^a   Chirico, Carla ^b   Di Donato, Pietro ^b   Campanati, Paolo ^c   Valcavi, Roberto ^d   Ceda, Gian Paolo ^a   Braverman, Lewis E ^e   Valenti, Giorgio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Ospedale di Cento Fe   (Italy)

^c Hospital of the Delta   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Estrogen; Menopause; Thyroid nodules

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; THYROTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; MENOPAUSAL SYNDROME; OUTCOME ASSESSMENT; POSTMENOPAUSE; THYROID FOLLICLE CELL; THYROID FUNCTION; THYROID NODULE; TREATMENT DURATION;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; THYROID GLAND; THYROID NODULE;

EID: 40449112975     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318148b83e     Document Type: Article

References (28)

1. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977;7:481-493.
2. Ericsson UB, Lindgarde F. The epidemiology of thyroid disorders in a seaport community in southern Sweden. J Clin Epidemiol 1990;43:645-650.
3. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol 2000;53:479-485.
4. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid 1999;9:631-635.
5. Delange F. The disorders induced by iodine deficiency. Thyroid 1994;4:107-128.
6. Valle LD, Ramina A, Vianello S, Fassina A, Belvedere P, Colombo L. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissue. J Clin Endocrinol Metab 1998;83:3702-3709.
7. Hiasa Y, Nishioka H, Kitahori Y, et al. Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 1993;50:132-136.
8. Bonacci R, Pinchera A, Fierabracci P, Gigliotti A, Grasso L, Giani C. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J Endocrinol Invest 1996;19:159-164.
9. Kawabata W, Suzuki T, Moriya T, et al. Estrogen receptor (alpha; and β) and 17β-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Mod Pathol 2003;16:437-444.
10. Ceresini G, Morganti S, Graiani V, et al. Estrogen receptor (ER)-β, but not ER-alpha;, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma. Thyroid 2006;16:1215-1220.
11. del Senno L, Degli Uberti E, Hanau S, Piva R, Rossi R, Trasforini G. In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids. Mol Cell Endocrinol 1989;63:67-74.
12. Furlanetto TW, Nguyen LQ, Jameson JL. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999;140:5705-5711.
13. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001;86:1072-1077.
14. Barrere X, Valeix P, Preziosi P, et al. Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clin Endocrinol (Oxf) 2000;52:273-278.
15. Knudsen N, Bulow I, Laurberg P, Perrild H, Ovesen L, Jorgensen T. Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol 2002;57:71-76.
16. Zini M, Poluzzi V, Bertani A, Portioli I, Cavalchi B, Valcavi R. Indagine epidemiologica sulla prevalenza del gozzo e sulla escrezione urinaria di iodio nella popolazione scolastica della provincia di Reggio Emilia. Ann Ist Super Sanità 1998;34:383-387.
17. Scheible W, Leopold GR, Woo VL, Gosink BB. High resolution realtime ultrasonography of thyroid nodules. Radiology 1979;133:413-417.
18. Rey-Stocker I, Zufferey MM, Lemarchand MT, Rais M. The sensibility of the hypophysis, the gonads and the thyroid of adolescents before and after the administration of oral contraceptives: a resume. Pediatr Ann 1981;10:15-20.
19. Ramey JN, Burrow GN, Polackwich RJ, Donabedian RK. The effect of oral contraceptive steroids on the response of thyroid-stimulating hormone to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1975;40:712-714.
20. Lisboa PC, Curty FH, Moreira RM, Pazos-Moura CC. Effects of estradiol benzoate on 5′-iodothyronine deiodinase activities in female rat anterior pituitary gland, liver and thyroid gland. Braz J Med Biol Res 1997;30:1479-1484.
21. Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentrations. J Clin Endocrinol Metab 1987;65:689-696.
22. Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 1992;2:237-245.
23. Mazer NA. Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women. Thyroid 2004;14:S27-S34.
24. Arafah BM. Increased need for thyroxine in women with hypothyroidism. N Engl J Med 2001;344:1743-1749.
25. Marqusee E, Braverman LE, Lawrence JE, Carrol JS, Seely EW. The effects of droloxifene and estrogen on thyroid function in postmenopausal women. J Clin Endocrinol Metab 2000;85:4407-4410.
26. Wang SH, Myc A, Koenig RJ, Bretz JD, Arscott PL, Baker JR. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis. Mol Cell Endocrinol 2000;165:163-172.
27. Vermiglio F, Lo Presti V, Violi MA, et al. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment. Clin Endocrinol 2003;59:347-353.
28. Koc M, Onder H, Akpinar I, Gogas-Yavuz D, Oguzhan D, Akalin S. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol 2002;57:621-628.